Metaclipse Therapeutics is a clinical stage biotech company developing next-generation immunotherapies to treat cancer & vaccines to prevent infectious diseases using our proprietary biological adjuvants. Our personalized immunotherapy platform, Membrex™, has demonstrated promising preclinical data across multiple solid tumors with Phase 1 clinical trials for triple negative breast cancer (TNBC) and head and neck cancer (HNSCC) underway. We are committed to continuous innovation using biological adjuvants for therapeutic and preventative vaccines.
Location: United States, California, Manteca
Investors 1
| Date | Name | Website |
| - | Georgia Re... | gra.org |
Mentions in press and media 1
| Date | Title | Description |
| 13.02.2025 | TMC names 2025 cohort of cancer treatment innovators | Texas Medical Center Innovation has named more than 50 health care innovators to the fifth cohort of its Accelerator for Cancer Therapeutics (ACT). The group specializes in immunotherapy, precision drug discovery, monoclonal antibodies, and... |